MS patient wins French vaccine case
This article was originally published in Scrip
Executive Summary
A French patient has won nearly €400,000 in damages from GlaxoSmithKline after a court agreed that her multiple sclerosis resulted from vaccination with GSK's Engerix B (hepatitis B vaccine).